I don't see that as safe because these medications haven't been tested in a population that's that young. This applies to both breastfeeding and pumping breast milk thats fed to a baby, she adds
December 2, 2024: 1,300 More People File Rybelsus and Other GLP-1 Lawsuits in November The multidistrict litigation lawsuit (MDL) against Rybelsus manufacturer Novo Nordisk and other GLP-1 manufacturers has 1,300 pending lawsuits as of December 2, 2024
Low Carb with GLP-1 Medications How to Eat if Youre on Ozempic or Similar Weight-Loss Drugs GLP-1 receptor agonist medications such as Ozempic, Wegovy, Mounjaro, and Zepbound have rapidly changed the landscape of weight loss and metabolic health
Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy
Protein intake deserves particular attention, with recommendations typically ranging from 1.0-1.2 grams per kilogram of body weight daily, individualized based on clinical status
Until such evidence is available for retatrutide, therapies with established cardiovascular and renal benefitssuch as semaglutide, supported by SUSTAIN-6 [5] and FLOW [57] trials in people with T2D, and the SELECT trial [58] in people with obesity - should be prioritised in populations with existing cardio-renal disease